0

baddrivers

Suit against maker of generic Reglan preempted 

  • by
    • July 1, 2013

A “failure to communicate” claim against the maker of generic Reglan was completely preempted by federal law regulating the pharmaceutical industry, the 11th U.S. Circuit Court of Appeals has ruled in affirming judgment.
The plaintiff alleged that she developed tardive dyskinesia as a result of taking metoclopramide, the generic form » […]

Original post by http://lawyersusaonline.com/blog/2013/07/01/suit-against-maker-of-generic-reglan-preempted/

Report bad drivers!

Related posts:

  1. Generic Reglan claim isn’t preempted  Federal law does not preempt a product liability suit against drug maker PLIVA based on the company’s alleged failure to...
  2. Generic drug user can sue brand-name manufacturer  State law allows the user of a generic drug to sue the maker of the name-brand drug for fraudulent misrepresentation,...
  3. Generic drug maker faces liability for out-of-date warning label  Federal law does not preempt a product liability suit alleging that the maker of a generic form of Fosamax failed...
  4. Justices: Generic drug design-defect claims preempted  WASHINGTON — In a victory to generic pharmaceutical companies, the U.S. Supreme Court ruled today that state design-defect laws that...
  5. Railroad crossing suit isn’t completely preempted  Federal transportation law does not completely preempt the state tort claims of a motorcyclist who suffered catastrophic injuries in a...

Leave a comment